Lambl’s excrescences are thin, thread-like strands of tissue that grow along the closing edges of heart valves. They develop from normal mechanical wear on the valve surface and are considered a common finding, not a disease in themselves. Most people who have them never know it. The clinical interest in these tiny filaments centers on rare but serious complications: when a strand or a clump of strands breaks free, it can travel through the bloodstream and block an artery, potentially causing a stroke or, in unusual cases, a heart attack.
What They Are and How They Form
Every time your heart beats, the valve leaflets snap shut under pressure. Over a lifetime, that repetitive mechanical stress causes microscopic damage to the valve surface. Lambl’s excrescences grow from that damage. Structurally, each excrescence is a slender filament with a dense core of collagen and elastic fibers, wrapped in a thin layer of endothelial cells, the same type of cells that line your blood vessels and heart chambers.1PubMed Central. Lambl’s Excrescences: Current Diagnosis and Management They typically measure just a few millimeters long, though some can be larger, and they wave back and forth with each heartbeat like seagrass in a current.
The growths were first described in 1856 by Vilém Dušan Lambl, a Bohemian physician who noticed these filiform lesions on aortic valve leaflets during autopsy examinations.2American Journal of Case Reports. Lambl’s Excrescence Associated with Cryptogenic Stroke: A Case Report and Literature Review For more than a century after that initial description, they were largely regarded as anatomical curiosities with no clinical significance. Interest picked up only when modern imaging technology made it possible to see these structures in living patients and correlate them with unexplained strokes.
Where They Grow and Who Has Them
Lambl’s excrescences show a clear preference for the left side of the heart. In studies that tracked valve excrescences across patient groups, the mitral valve was the most common site, hosting excrescences in roughly 68% to 76% of affected individuals. The aortic valve came next, at about 38% to 50%. Right-sided valves, the tricuspid and pulmonary, were involved in fewer than 10% of cases.3Journal of the American College of Cardiology. Valve Excrescences: Prevalence, Evolution and Risk for Cardioembolism On the mitral valve, they tend to appear on the atrial surface; on the aortic valve, on the ventricular surface. Rare cases have been reported on prosthetic valves as well.
The same research found that excrescences occurred equally in men and women and showed no significant increase with age across the groups studied.4Journal of the American College of Cardiology. Valve Excrescences: Prevalence, Evolution and Risk for Cardioembolism This is somewhat counterintuitive: since wear and tear accumulates over decades, you might expect older people to have more of them. But the formation process seems to reach a kind of plateau. Many adults have at least small excrescences without ever experiencing problems.
How They Are Detected
Because Lambl’s excrescences are so small and thin, a standard transthoracic echocardiogram (the type where a probe is pressed against your chest) often misses them entirely. The gold standard for detection is transesophageal echocardiography, or TEE, in which a specialized ultrasound probe is passed down the esophagus to get much closer to the heart.5PubMed Central. Lambl’s Excrescence as an Etiology of Thromboembolism: Case Report and Literature Review The proximity makes it possible to resolve filaments that are only a millimeter or two wide. Because of this sensitivity, TEE has been recommended in the diagnostic workup for patients who have experienced strokes without a clear cause.6PubMed Central. Lambl’s excrescences: review and recommendations
Three-dimensional TEE pushes the diagnostic picture further. Compared to conventional two-dimensional TEE, 3D imaging detected a notably higher number of excrescences in one comparative study (19 versus 11 on the same set of aortic valves) and was the only technique that could reliably identify the exact cusp attachment site and the three-dimensional orientation of each filament.7PubMed. Incremental value of three-dimensional transesophageal echocardiography over two-dimensional transesophageal echocardiography in the assessment of Lambl’s excrescences and nodules of Arantius on the aortic valve That spatial detail can matter when surgeons need to plan an excision or when clinicians are trying to distinguish an excrescence from something more dangerous.
The Embolic Risk
The reason cardiologists pay attention to Lambl’s excrescences at all is their potential to throw off emboli, small clots or tissue fragments that travel through the bloodstream and lodge in distant arteries. When multiple excrescences clump together, they create a fragile mass that turbulent blood flow can shear off.8OA Text. Lambl’s excrescences: A case report and review of the literature Because the growths sit on left-sided valves, any fragment that breaks free enters the systemic arterial circulation and can end up anywhere: the brain, the coronary arteries, the kidneys, or the limbs.
Stroke, particularly what is called a cryptogenic stroke (one where standard workup fails to find a cause), is the complication most frequently linked to these growths. In younger patients who suffer a stroke without typical risk factors like high blood pressure, atrial fibrillation, or carotid artery disease, clinicians sometimes discover Lambl’s excrescences during the search for an embolic source.9American Journal of Case Reports. Lambl’s Excrescence Associated with Cryptogenic Stroke: A Case Report and Literature Review
Coronary embolism is rarer but documented. One reported case involved a 43-year-old man with no history of coronary artery disease who presented with chest pain and elevated cardiac enzymes consistent with a heart attack. Investigation traced the event back to excrescences on his aortic valve.10PubMed. Acute myocardial infarction from embolization of Lambl’s excrescences: A case report Cases like this are uncommon enough to be published individually, which itself speaks to how rarely coronary embolism from excrescences occurs. Still, the case illustrates a broader principle: a heart attack in a patient with clean coronary arteries and no obvious risk factors should prompt a careful look at the heart valves for embolic sources.
Telling Them Apart from Other Valve Masses
Finding a small structure waving on a heart valve creates a differential diagnosis puzzle. The two most important alternatives a clinician has to rule out are cardiac papillary fibroelastoma and infective endocarditis vegetations. Getting this distinction right matters, because the treatment paths diverge sharply.
Papillary fibroelastomas are benign tumors that share some microscopic features with Lambl’s excrescences. Both contain collagen and elastic fibers covered by endothelium. The differences are in size, location, and architecture. Excrescences are smaller, sit right on the line where the valve leaflets meet when closed, and are covered by a single layer of endothelial cells. Fibroelastomas tend to be bulkier, often with fingerlike projections on their surface and multiple endothelial layers. They typically grow away from the line of valve closure, on mechanically less pressured parts of the valve or even on other areas of the heart’s inner lining.11PubMed Central. Lambl’s Excrescences and Cardiac Papillary Fibroelastoma, an Unusual Cause of Embolic Strokes: Extended Data From a Single Center Case Series One reason excrescences stay small may be that their exposed position at the valve closure line subjects them to constant shearing forces that limit growth, while fibroelastomas grow in calmer hemodynamic neighborhoods.
Even with TEE, distinguishing the two on imaging alone is not always possible. The American Society of Echocardiography has noted that definitive diagnosis sometimes requires histopathologic confirmation, meaning the tissue actually has to be examined under a microscope after surgical removal. Some excrescences and fibroelastomas are microscopically indistinguishable, and the separation ultimately relies on gross and clinical features rather than unique imaging findings.12PubMed Central. Lambl’s Excrescences and Cardiac Papillary Fibroelastoma, an Unusual Cause of Embolic Strokes: Extended Data From a Single Center Case Series Without surgical excision, the TEE-based diagnosis is best understood as a “most probable” diagnosis rather than a definitive one.
Infective endocarditis, an infection of the valve, produces vegetations that can look superficially similar on ultrasound but carry vastly different implications. In a reported case, a 9-year-old boy was found to have a small filamentous structure on his aortic valve. The initial suspicion was infective endocarditis, and antibiotics were started. Transesophageal echocardiography, however, showed no features consistent with vegetations, fibroelastomas, or thrombi, and repeated blood cultures came back negative, leading clinicians to conclude the structure was a Lambl’s excrescence.13Fujita Medical Journal. Lambl’s excrescences in a 9-year-old japanese boy: differentiation from infective endocarditis The key clinical clues that point away from endocarditis include negative blood cultures, absence of fever or systemic infection signs, and the filamentous rather than irregular morphology of the structure on detailed imaging.
Management When They Are Found
What happens after a Lambl’s excrescence is identified depends almost entirely on whether it has caused symptoms. The evidence here, while limited to case series and expert opinion rather than large randomized trials, follows a fairly consistent stepwise logic.
When excrescences are found incidentally in someone who has never had a stroke or embolic event, the standard recommendation is close monitoring rather than any active treatment.14PubMed Central. Lambl’s excrescences: review and recommendations The vast majority of people with these structures never develop complications, and the risks of anticoagulation or surgery would outweigh any likely benefit.
After a first stroke or transient ischemic attack attributed to excrescences, the recommended step is anticoagulation therapy, typically with blood thinners intended to prevent clot formation on or around the filaments. If there is evidence of a second cerebrovascular event despite anticoagulation, surgical removal of the excrescences is advised.15PubMed Central. Lambl’s excrescences: review and recommendations The logic is straightforward: a single event might be managed medically, but recurrence signals that medication alone is not keeping the embolic risk under control.
Surgical excision has been performed successfully in published series. In a review of seven cases that went to surgery, there were no complications or operative deaths.16PubMed. Diagnosis and Treatment of Lambl’s Excrescence on the Aortic Valve Surgery is also recommended for patients who have excrescences and need open-heart surgery for another reason, since the additional step of shaving off the growths adds minimal risk when the chest is already open. One case report described resecting excrescences from the aortic valve during a mitral valve replacement and left atrial thrombus removal, keeping the aortic valve leaflets and function intact.17PubMed. Resection of Lambl’s excrescence on the aortic valve in a patient with rheumatic mitral valve disease and a left atrial thrombus The low added morbidity of excising excrescences during an already-planned cardiac surgery makes this an easy decision compared to the dilemma of opening the chest solely for excrescences.
Lambl’s Excrescences in Children
Although the wear-and-tear explanation might suggest these growths are exclusive to adults, they have been documented in pediatric patients, including infants. In a study of 700 children undergoing echocardiography, about 1.7% were found to have Lambl’s excrescences. The youngest patient was just five months old. The presence of excrescences was not related to age within the pediatric group, and during long-term follow-up none of the 12 identified children experienced clinical events such as stroke.18PubMed. Lambl’s excrescences in children: Improved detection via transthoracic echocardiography
A separate case series specifically looked at excrescences in the context of congenital heart disease. Among 17 patients with excrescences, nearly two-thirds were under 18 years of age. In almost all cases the excrescences were located on the aortic valve, and about half the patients had an underlying congenital heart defect such as a ventricular septal defect, bicuspid aortic valve, or tetralogy of Fallot.19Exploratory Research and Hypothesis in Medicine. Lambl’s Excrescences in Congenital Heart Disease and Other Clinical Situations: A Series of 17 Cases The association with congenital defects makes some hemodynamic sense: abnormal valve anatomy could create unusual flow patterns and mechanical stress that accelerates the kind of endothelial damage that seeds excrescence growth, even in a young heart.
For pediatric cardiologists, the finding of an excrescence raises the same differential diagnosis issues as in adults, with the added wrinkle that parents naturally worry about any growth found on their child’s heart. The reassuring data so far suggest that in children, excrescences behave benignly. Still, the case literature is small enough that definitive statements about long-term pediatric risk remain premature. The 9-year-old Japanese boy initially suspected of having endocarditis is a useful illustration of how an excrescence can mimic a more alarming condition and lead to unnecessary treatment before the correct diagnosis is reached.20Fujita Medical Journal. Lambl’s excrescences in a 9-year-old japanese boy: differentiation from infective endocarditis
Why the Evidence Base Remains Thin
One of the frustrations with Lambl’s excrescences is that, despite being described more than 160 years ago, the literature consists almost entirely of case reports, small case series, and expert reviews. There are no randomized controlled trials comparing anticoagulation strategies, no large prospective cohort studies tracking embolic event rates over time, and no standardized imaging criteria that reliably separate excrescences from fibroelastomas in every case. The rarity of symptomatic complications is part of the problem: when a condition almost never causes harm, there is little motivation or statistical power to run the kind of large trials that settle clinical questions definitively.
This leaves clinicians in a familiar gray zone. A patient who has had a cryptogenic stroke and is found to have excrescences on TEE faces a probabilistic judgment call. The excrescences could be the source of the stroke, but proving that relationship in any individual case is essentially impossible without catching the embolism in the act. Some experts have argued that TEE should be part of the standard workup for every cryptogenic stroke specifically to catch embolic sources like excrescences.21PubMed Central. Lambl’s excrescences: review and recommendations Others counter that, given how common excrescences are in the general population, finding one on a stroke patient’s valve does not necessarily mean it caused the event. The coincidence problem is real: if a large fraction of healthy people have excrescences, any stroke patient has a reasonable chance of having them too, regardless of whether they played a role.
What the field needs is a well-designed registry that tracks patients with identified excrescences over years, recording baseline valve morphology, excrescence characteristics, treatment decisions, and outcomes. Until that data exists, management will continue to rest on the cautious, case-by-case framework that currently guides practice: watch the asymptomatic, anticoagulate after a first event, and operate after recurrence or when the chest is already open for another reason.
Lambl’s Excrescences Found During Unrelated Heart Surgery
A scenario that comes up more often than you might expect is the incidental discovery of excrescences during cardiac surgery performed for an entirely different reason, such as valve replacement for rheumatic heart disease or repair of a congenital defect. Surgeons in that position face a low-stakes decision with a clear upside. Because excising the filaments from a valve adds only seconds to the procedure and carries minimal additional risk to the valve leaflets or their function, most teams will remove them.22PubMed. Resection of Lambl’s excrescence on the aortic valve in a patient with rheumatic mitral valve disease and a left atrial thrombus The reasoning is prophylactic: even though the excrescences may never have caused trouble, removing them eliminates any future embolic potential from that source.
This opportunistic approach also gives pathologists a chance to examine the tissue under a microscope, which can retroactively clarify whether the structure was truly an excrescence or a small fibroelastoma. Given the diagnostic ambiguity on imaging, the histologic confirmation that comes from intraoperative excision adds certainty to the patient’s record and can influence long-term surveillance decisions. For patients who had unexplained neurological events before surgery, finding classic excrescence histology may retrospectively solve the diagnostic puzzle that prompted the stroke workup in the first place.